Idera Pharmaceuticals, Inc. (IDRA) Social Stream



Idera Pharmaceuticals, Inc. (IDRA): $0.40

0.01 (+3.70%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add IDRA to Watchlist
Sign Up

Industry: Biotech


Ranked

of 465

in industry

IDERA PHARMACEUTICALS INC (IDRA) Price Targets From Analysts

Use the tables below to see what analysts covering IDERA PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-03-19 1 $2 $2 $2 $0.451 343.46%

Price Target Last Issued March 19, 2021

The Trend in the Analyst Price Target


IDRA's average price target has moved down $6.6 over the prior 15 months.

500 - Internal server error

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential

IDRA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3 0 0 1 0 0 1

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • To contextualize these metrics, consider that out of all US stocks, IDERA PHARMACEUTICALS INC's number of analysts covering the stock is higher than practically none of them.
  • IDRA has a lower variance in analysts' estimates than nearly 100% of all US stocks.
  • IDRA has a higher average analyst price target than 0.98% of Healthcare stocks.
  • IDERA PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 75.05% of stocks in the small market cap category.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to IDERA PHARMACEUTICALS INC are ICVX, HUMA, and HLVX.

Make investment decisions regarding IDRA using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4905 seconds.